Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSMA PET/CT + mpMRI vs mpMRI Alone for Prostate Biopsy Guidance
NCT05820724Phase 2Not yet recruiting
- Sponsor
- VA Greater Los Angeles Healthcare System
- Start
- May 2023
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of piflufolastat f 18 in prostate cancer (PCa), sponsored by VA Greater Los Angeles Healthcare System. Planned start May 2023; status: not yet recruiting.
02
Drugs
piflufolastat f 18
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT05820724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05820724.